Owing to the highly specific expression of ASGR1 on the surface of hepatocytes and its efficient endocytic capability, this receptor has been extensively utilized in the development of targeted therapeutic strategies for viral infections, particularly for the precision treatment of chronic hepatitis B (CHB) (116). This evidence concerns the gene ASGR1 and viral infectious disease.